1. Ten-year trend of care practices, morbidities and survival of very preterm neonates in the Malaysian National Neonatal Registry: a retrospective cohort study
- Author
-
Seok Chiong Chee, Ee Lee Ang, Farah Inaz Syed-Abdullah, Nem-Yun Boo, Pauline Choo, Ann Cheng Wong, Siew Hong Neoh, Eric Boon-Kuang Ang, and Azanna Ahmad Kamar
- Subjects
medicine.medical_specialty ,Pediatrics ,Neonatal intensive care unit ,Infant, Premature, Diseases ,Surfactant therapy ,Antenatal steroid ,RJ1-570 ,Pregnancy ,Intensive care ,Humans ,Medicine ,Registries ,Neonatology ,music ,Retrospective Studies ,music.instrument ,Cesarean Section ,business.industry ,Infant, Newborn ,Retrospective cohort study ,medicine.disease ,Bronchopulmonary dysplasia ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Lower segment caesarean section ,epidemiology ,Female ,Morbidity ,business - Abstract
ObjectivesTo determine a 10-year trend of survival, morbidities and care practices, and predictors of in-hospital mortality in very preterm neonates (VPTN, gestation 22 to DesignRetrospective cohort study.Setting43 Malaysian neonatal intensive care units.Patients29 010 VPTN (without major malformations) admitted between 1 January 2009 and 31 December 2018.Main outcome measuresCare practices, survival, admission hypothermia (AH, ResultsDuring this 10-year period, there was increased use of antenatal steroid (ANS), lower segment caesarean section (LSCS) and early continuous positive airway pressure (eCPAP); but decreased use of surfactant therapy. Survival had increased from 72% to -83.9%. The following morbidities had decreased: LOS (from 27.9% to 7.1%), pneumothorax (from 6.0% to 2.7%), NEC (from 8.1% to 4.7%) and sIVH (from 12.2% to 7.5%). However, moderately severe AH (32.0°Cā35.9°C) and BPD had increased. Multiple logistic regression analyses showed that lower birth weight, no ANS, no LSCS, admission to neonatal intensive care unit with ConclusionSurvival and major morbidities had improved modestly. Failure to use ANS, LSCS, eCPAP and surfactant therapy, and failure to prevent AH and LOS increased risk of mortality.
- Published
- 2021